Post-hypoglycemic nocturnal hyperglycemia in type 1 diabetes: the Somogyi hypothesis revisited
Tomás González-Vidal1,2,3, Diego Rivas-Otero4,5,6, Pablo Agüeria-Cabal4
1Department of Endocrinology and Nutrition, Hospital Universitario Central de Asturias/University of Oviedo, Oviedo, Spain. uo302763@uniovi.es.
Purpose:
The plausibility of the Somogyi phenomenon (dawn hyperglycemia after nocturnal hypoglycemia) has been questioned. The present study used continuous glucose monitoring in patients with type 1 diabetes (T1DM) to investigate the frequency and the associated factors for post-hypoglycemic nocturnal hyperglycemia (PHNH), as well as the overall glycemic control in patients who develop PHNH.
Methods:
This study analyzed the nighttime (0:00 am to 6:00 am) glycemic profile of 755 FreeStyle Libre 2 users with T1DM (429 men; median age 49 years, range 18-90 years) during a 14-day period. Patients were divided into three categories, as follows: no nocturnal hypoglycemia (< 70 mg/dL), only nocturnal hypoglycemia that was not followed by hyperglycemia (> 180 mg/dL) before 6:00 am, and ≥ 1 episode of nocturnal hypoglycemia that was followed by hyperglycemia before 6:00 am (PHNH). The patients' characteristics and the overall glycemic control in the 14-day period were also registered.
Results:
A total of 248 patients (32.8%) developed PHNH during the 14-day period. Compared with patients who only had nocturnal hypoglycemia that was not followed by hyperglycemia (n = 332), patients with PHNH were younger, were less frequently diagnosed as latent autoimmune diabetes in adults (LADA), and used higher total daily doses of insulin. Patients with PHNH had longer time above range, shorter time in range, higher glucose variability, and more diurnal hypoglycemia than those who only had nocturnal hypoglycemia that was not followed by hyperglycemia before 6:00 am.
Conclusions:
PHNH is frequent in T1DM, especially in young individuals. Compared to patients with other forms of nocturnal hypoglycemia, patients with PHNH have poorer glycemic control.
Related Concept Videos
Hypoglycemia and Glucagon
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Diabetes Mellitus: Type 2 and Gestational
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Diabetes: Symptoms, Diagnosis, and Complications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...


